Microbix Biosystems Inc. (MBXBF)
- Previous Close
0.2900 - Open
0.2775 - Bid 0.2720 x --
- Ask 0.2772 x --
- Day's Range
0.2775 - 0.2775 - 52 Week Range
0.2000 - 0.3870 - Volume
500 - Avg. Volume
30,858 - Market Cap (intraday)
39.304M - Beta (5Y Monthly) 0.29
- PE Ratio (TTM)
27.75 - EPS (TTM)
0.0100 - Earnings Date May 13, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
www.microbix.comRecent News: MBXBF
View More
Performance Overview: MBXBF
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MBXBF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MBXBF
View MoreValuation Measures
Market Cap
39.96M
Enterprise Value
35.18M
Trailing P/E
28.64
Forward P/E
40.16
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.39
Price/Book (mrq)
1.96
Enterprise Value/Revenue
2.11
Enterprise Value/EBITDA
10.43
Financial Highlights
Profitability and Income Statement
Profit Margin
8.35%
Return on Assets (ttm)
3.79%
Return on Equity (ttm)
6.85%
Revenue (ttm)
23.03M
Net Income Avi to Common (ttm)
1.92M
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
13.05M
Total Debt/Equity (mrq)
22.29%
Levered Free Cash Flow (ttm)
566.28k